Active Claim Investigation

Cancer After Taking Zantac for Heartburn?

Ranitidine products were removed from the market in 2020 after tests showed they could form NDMA, a probable carcinogen. Long-term users are filing claims.

Start My Free Case Reviewor call (800) 555-0199

About the Zantac (Ranitidine) litigation

Zantac (ranitidine) was one of the best-selling heartburn medications in history, used daily by millions of Americans. In 2019, independent laboratory testing found that ranitidine could degrade into N-nitrosodimethylamine (NDMA) — a probable human carcinogen — especially when exposed to heat or stored for long periods.

In April 2020, the FDA requested the removal of all ranitidine products from the U.S. market. Lawsuits allege that manufacturers knew or should have known about NDMA formation and failed to warn consumers.

If you took Zantac or generic ranitidine regularly and were later diagnosed with bladder, stomach, esophageal, liver, or pancreatic cancer, you may be eligible to file a claim.

Zantac (Ranitidine) FAQ

Does the new 'Zantac 360' count?

No. Zantac 360 uses famotidine, a different drug that is not part of this litigation. Claims involve the original ranitidine formulation sold before the 2020 withdrawal.

I took generic ranitidine, not brand-name Zantac. Do I qualify?

Possibly. Eligibility can depend on whether you took brand-name or generic products and in which state you file. A case review will sort this out at no cost.

What proof of usage do I need?

Pharmacy records and prescriptions are strongest, but purchase records, medical charts noting the medication, and personal testimony also help.

Ready to find out if you qualify?

Answer a few questions about your exposure and diagnosis. It takes about five minutes.

Start My Free Case Reviewor call (800) 555-0199